data_7k1m_residue ############################ # Computer software used # ############################ save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 7k1m _Structure_validation_residue.Date_analyzed 2020-11-27 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.363 0 N-CA-C 112.512 -0.235 . . . . 72.439999999999998 112.512 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 9.9 m -105.14 154.68 19.85 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.851 0.358 . . . . 75.329999999999998 110.847 -179.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 6.9 p80 -133.06 141.99 48.52 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.159 -0.473 . . . . 74.349999999999994 110.853 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -85.05 107.58 17.23 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.203 -0.453 . . . . 72.299999999999997 110.937 -179.837 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -103.16 161.56 22.74 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.606 0.717 . . . . 72.430000000000007 111.158 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.73 -19.88 35.67 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.673 2.249 . . . . 75.120000000000005 112.344 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 10.2 m-85 -97.04 -31.7 12.37 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.198 -0.455 . . . . 75.519999999999996 110.841 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 161.63 138.62 2.46 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.736 -0.745 . . . . 52.240000000000002 112.489 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -53.85 134.63 42.62 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.773 0.32 . . . . 74.329999999999998 110.897 -179.916 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 8.2 mt -131.39 143.58 40.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.251 -0.431 . . . . 73.430000000000007 111.136 179.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -127.78 143.98 51.11 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.167 -0.47 . . . . 65.239999999999995 110.855 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 6.7 m-85 . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 116.131 -0.486 . . . . 74.129999999999995 110.87 -179.957 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.335 0 N-CA-C 112.492 -0.243 . . . . 73.519999999999996 112.492 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 10.1 m -96.27 154.68 17.12 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.862 0.363 . . . . 74.430000000000007 110.846 -179.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 6.9 p80 -133.0 141.41 48.27 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.151 -0.477 . . . . 72.5 110.857 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -84.63 107.41 16.83 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.227 -0.442 . . . . 72.030000000000001 110.865 -179.841 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.401 ' HB ' ' HD2' ' A' ' 6' ' ' PRO . 0.1 OUTLIER -102.97 161.52 22.87 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.617 0.723 . . . . 74.030000000000001 111.125 -179.989 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.401 ' HD2' ' HB ' ' A' ' 5' ' ' THR . 54.6 Cg_endo -69.74 -19.74 35.84 Favored 'Trans proline' 0 C--O 1.231 0.16 0 C-N-CA 122.716 2.278 . . . . 62.350000000000001 112.372 179.916 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 10.3 m-85 -97.1 -31.7 12.34 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.213 -0.448 . . . . 73.510000000000005 110.848 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 161.63 138.56 2.45 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.766 -0.73 . . . . 63.509999999999998 112.49 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -53.85 134.48 42.65 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.749 0.309 . . . . 73.450000000000003 110.895 -179.92 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 7.9 mt -131.32 143.51 40.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.169 -0.468 . . . . 73.209999999999994 111.149 179.836 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -127.65 145.33 50.92 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.18 -0.463 . . . . 70.239999999999995 110.847 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 6.5 m-85 . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.149 -0.478 . . . . 74.230000000000004 110.866 179.997 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.336 0 N-CA-C 112.494 -0.243 . . . . 74.299999999999997 112.494 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 9.9 m -102.14 154.58 18.88 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.805 0.336 . . . . 73.549999999999997 110.927 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 6.9 p80 -132.99 141.93 48.57 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.218 -0.446 . . . . 72.340000000000003 110.886 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -84.95 107.77 17.25 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.205 -0.452 . . . . 73.150000000000006 110.946 -179.862 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -103.32 161.57 22.66 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.569 0.699 . . . . 73.120000000000005 111.108 -179.933 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.77 -19.87 35.51 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.656 2.238 . . . . 74.140000000000001 112.376 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 10.1 m-85 -97.06 -31.66 12.38 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.172 -0.467 . . . . 64.230000000000004 110.883 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 161.62 138.63 2.46 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.761 -0.733 . . . . 73.439999999999998 112.492 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -53.92 134.63 43.0 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.832 0.348 . . . . 73.329999999999998 110.931 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 8.2 mt -131.38 143.55 40.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.187 -0.461 . . . . 72.420000000000002 111.143 179.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -127.65 144.74 51.05 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.157 -0.474 . . . . 74.120000000000005 110.848 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 6.0 m-85 . . . . . 0 C--N 1.329 -0.315 0 CA-C-N 116.142 -0.481 . . . . 71.219999999999999 110.932 -179.992 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.369 0 N-CA-C 112.47 -0.252 . . . . 74.219999999999999 112.47 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 9.7 m -95.45 154.47 17.19 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.876 0.37 . . . . 71.349999999999994 110.864 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 6.9 p80 -132.76 141.82 48.71 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.191 -0.459 . . . . 64.219999999999999 110.887 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -84.94 107.4 17.06 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.194 -0.457 . . . . 73.420000000000002 110.889 -179.801 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.403 ' HB ' ' HD2' ' A' ' 6' ' ' PRO . 0.1 OUTLIER -102.95 161.52 22.88 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.535 0.683 . . . . 74.030000000000001 111.165 -179.995 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.403 ' HD2' ' HB ' ' A' ' 5' ' ' THR . 53.3 Cg_endo -69.83 -19.67 35.48 Favored 'Trans proline' 0 N--CA 1.465 -0.161 0 C-N-CA 122.694 2.263 . . . . 74.439999999999998 112.338 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 10.4 m-85 -97.13 -31.65 12.36 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.186 -0.461 . . . . 73.120000000000005 110.899 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 161.5 138.48 2.43 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.788 -0.72 . . . . 61.049999999999997 112.54 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -53.79 134.5 42.3 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.794 0.331 . . . . 73.430000000000007 110.93 -179.905 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 7.8 mt -131.35 143.63 40.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.187 -0.461 . . . . 73.340000000000003 111.085 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -127.7 145.49 50.88 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.159 -0.473 . . . . 73.329999999999998 110.877 179.95 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 7.2 m-85 . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.2 -0.454 . . . . 71.209999999999994 110.865 -179.947 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.342 0 N-CA-C 112.51 -0.236 . . . . 63.030000000000001 112.51 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 9.8 m -104.46 154.37 19.96 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.877 0.37 . . . . 63.450000000000003 110.901 -179.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 6.9 p80 -133.03 142.6 48.89 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.178 -0.465 . . . . 75.219999999999999 110.839 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -85.66 107.57 17.61 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.255 -0.429 . . . . 75.519999999999996 110.922 -179.855 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.401 ' HB ' ' HD2' ' A' ' 6' ' ' PRO . 0.1 OUTLIER -103.14 161.57 22.69 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.616 0.722 . . . . 75.540000000000006 111.102 -179.943 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.401 ' HD2' ' HB ' ' A' ' 5' ' ' THR . 53.8 Cg_endo -69.8 -19.62 35.68 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.683 2.256 . . . . 64.140000000000001 112.319 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 10.3 m-85 -97.17 -31.67 12.34 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.226 -0.443 . . . . 73.430000000000007 110.87 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 161.5 138.6 2.46 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.796 -0.716 . . . . 62.149999999999999 112.507 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -53.84 134.52 42.56 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.796 0.331 . . . . 75.510000000000005 110.924 -179.943 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 7.9 mt -131.32 143.63 40.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.177 -0.465 . . . . 75.019999999999996 111.14 179.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -127.85 145.33 50.97 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.137 -0.483 . . . . 64.329999999999998 110.884 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 7.6 m-85 . . . . . 0 C--N 1.328 -0.348 0 CA-C-N 116.156 -0.475 . . . . 74.129999999999995 110.896 -179.98 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.33 0 N-CA-C 112.503 -0.239 . . . . 74.230000000000004 112.503 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 9.5 m -103.59 154.43 19.5 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.887 0.375 . . . . 73.25 110.867 -179.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 6.9 p80 -132.59 141.71 48.81 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.13 -0.486 . . . . 64.530000000000001 110.834 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -84.72 107.62 17.01 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.178 -0.465 . . . . 71.129999999999995 110.915 -179.833 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -103.23 161.58 22.65 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.629 0.728 . . . . 61.229999999999997 111.13 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.74 -19.88 35.65 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.731 2.288 . . . . 73.019999999999996 112.322 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 10.1 m-85 -97.0 -31.84 12.31 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.231 -0.44 . . . . 72.140000000000001 110.89 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 161.66 138.57 2.45 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.732 -0.747 . . . . 73.510000000000005 112.48 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -53.79 134.55 42.31 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.815 0.341 . . . . 74.239999999999995 110.892 -179.927 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 8.0 mt -131.32 143.57 40.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.218 -0.446 . . . . 72.019999999999996 111.109 179.81 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -127.5 144.56 51.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.147 -0.479 . . . . 71.430000000000007 110.872 179.885 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 116.18 -0.464 . . . . 75.349999999999994 110.84 -179.956 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.357 0 N-CA-C 112.478 -0.249 . . . . 74.030000000000001 112.478 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 9.5 m -91.76 154.36 18.99 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.896 0.379 . . . . 74.099999999999994 110.903 -179.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 6.9 p80 -132.97 142.47 48.88 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.19 -0.459 . . . . 71.420000000000002 110.856 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -85.53 107.47 17.48 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.224 -0.443 . . . . 71.439999999999998 110.906 -179.846 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.403 ' HB ' ' HD2' ' A' ' 6' ' ' PRO . 0.1 OUTLIER -103.02 161.59 22.65 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-O 121.604 0.716 . . . . 75.420000000000002 111.122 -179.967 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.403 ' HD2' ' HB ' ' A' ' 5' ' ' THR . 53.3 Cg_endo -69.79 -19.77 35.54 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.731 2.287 . . . . 73.010000000000005 112.313 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 10.3 m-85 -97.06 -31.63 12.39 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.19 -0.459 . . . . 75.439999999999998 110.876 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 161.44 138.6 2.46 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.736 -0.745 . . . . 54.450000000000003 112.469 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -53.78 134.55 42.23 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.826 0.346 . . . . 75.430000000000007 110.919 -179.929 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 7.9 mt -131.36 143.56 40.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.137 -0.483 . . . . 74.200000000000003 111.116 179.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -127.85 144.4 51.09 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.2 -0.454 . . . . 72.209999999999994 110.859 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 7.2 m-85 . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 116.167 -0.469 . . . . 71.239999999999995 110.878 -179.947 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.335 0 N-CA-C 112.44 -0.264 . . . . 70.420000000000002 112.44 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 9.6 m -100.2 154.71 18.23 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.91 0.386 . . . . 73.129999999999995 110.889 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 6.9 p80 -133.1 141.52 48.23 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.163 -0.471 . . . . 73.150000000000006 110.829 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -84.66 107.48 16.89 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.208 -0.451 . . . . 74.200000000000003 110.888 -179.844 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.401 ' HB ' ' HD2' ' A' ' 6' ' ' PRO . 0.1 OUTLIER -103.05 161.56 22.73 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.6 0.714 . . . . 71.420000000000002 111.135 179.989 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.401 ' HD2' ' HB ' ' A' ' 5' ' ' THR . 53.9 Cg_endo -69.82 -19.74 35.44 Favored 'Trans proline' 0 C--O 1.231 0.17 0 C-N-CA 122.704 2.27 . . . . 74.5 112.324 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 10.3 m-85 -97.1 -31.63 12.38 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.229 -0.441 . . . . 64.530000000000001 110.862 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 161.56 138.57 2.45 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.77 -0.729 . . . . 75.150000000000006 112.529 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -53.87 134.59 42.75 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.826 0.345 . . . . 74.319999999999993 110.893 -179.918 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 8.0 mt -131.37 143.4 40.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.156 -0.474 . . . . 73.519999999999996 111.141 179.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -127.76 144.03 51.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.178 -0.464 . . . . 70.409999999999997 110.872 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 6.9 m-85 . . . . . 0 C--N 1.328 -0.33 0 CA-C-N 116.196 -0.456 . . . . 72.420000000000002 110.877 -179.968 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.302 0 N-CA-C 112.495 -0.242 . . . . 73.349999999999994 112.495 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 9.7 m -102.57 154.71 18.86 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.852 0.358 . . . . 73.140000000000001 110.901 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 6.9 p80 -133.04 141.85 48.46 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.212 -0.449 . . . . 62.310000000000002 110.887 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -84.98 107.53 17.15 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.195 -0.457 . . . . 75.140000000000001 110.927 -179.85 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.403 ' HB ' ' HD2' ' A' ' 6' ' ' PRO . 0.1 OUTLIER -103.12 161.56 22.74 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.55 0.69 . . . . 72.019999999999996 111.13 -179.97 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.403 ' HD2' ' HB ' ' A' ' 5' ' ' THR . 53.7 Cg_endo -69.75 -19.64 35.92 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.633 2.222 . . . . 74.239999999999995 112.336 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 10.4 m-85 -97.16 -31.76 12.3 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.221 -0.445 . . . . 75.010000000000005 110.894 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 161.64 138.67 2.47 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.737 -0.744 . . . . 71.239999999999995 112.483 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -53.88 134.54 42.81 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.764 0.316 . . . . 74.120000000000005 110.879 -179.91 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 8.0 mt -131.42 143.67 39.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.187 -0.461 . . . . 74.409999999999997 111.16 179.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -127.67 139.1 52.92 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.186 -0.461 . . . . 73.019999999999996 110.86 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 6.2 m-85 . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.14 -0.482 . . . . 74.519999999999996 110.877 179.999 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.325 0 N-CA-C 112.469 -0.252 . . . . 72.439999999999998 112.469 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 9.5 m -96.04 154.42 17.25 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.87 0.367 . . . . 75.340000000000003 110.885 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 6.9 p80 -133.01 142.82 49.03 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.204 -0.453 . . . . 75.439999999999998 110.909 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -85.79 107.79 17.8 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.215 -0.448 . . . . 75.439999999999998 110.907 -179.822 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -103.29 161.62 22.53 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.588 0.709 . . . . 74.340000000000003 111.14 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.84 -19.55 35.58 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.665 2.243 . . . . 72.420000000000002 112.316 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 10.3 m-85 -97.33 -31.8 12.21 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.24 -0.436 . . . . 75.030000000000001 110.846 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 161.68 138.75 2.49 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.768 -0.73 . . . . 54.530000000000001 112.491 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -53.84 134.64 42.56 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.77 0.319 . . . . 73.439999999999998 110.933 -179.912 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 8.8 mt -131.31 143.44 40.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.193 -0.458 . . . . 62.409999999999997 111.112 179.841 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -127.89 145.1 51.06 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.207 -0.451 . . . . 72.409999999999997 110.874 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 . . . . . 0 C--N 1.33 -0.263 0 CA-C-N 116.168 -0.469 . . . . 71.120000000000005 110.882 -179.965 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.301 0 N-CA-C 112.533 -0.227 . . . . 62.329999999999998 112.533 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 9.8 m -99.87 154.7 18.14 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.829 0.347 . . . . 75.340000000000003 110.888 -179.898 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 6.9 p80 -133.03 142.36 48.76 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.188 -0.46 . . . . 74.140000000000001 110.863 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -85.38 107.75 17.51 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.25 -0.432 . . . . 63.539999999999999 110.973 -179.89 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.4 ' HB ' ' HD2' ' A' ' 6' ' ' PRO . 0.1 OUTLIER -103.32 161.55 22.72 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.619 0.723 . . . . 74.340000000000003 111.12 -179.942 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.4 ' HD2' ' HB ' ' A' ' 5' ' ' THR . 53.8 Cg_endo -69.72 -19.49 36.26 Favored 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.687 2.258 . . . . 71.5 112.342 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 10.4 m-85 -97.43 -31.84 12.16 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.218 -0.446 . . . . 72.329999999999998 110.855 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 161.72 138.64 2.47 Favored Glycine 0 N--CA 1.451 -0.367 0 C-N-CA 120.757 -0.735 . . . . 52.219999999999999 112.479 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -53.82 134.53 42.47 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.808 0.337 . . . . 73.129999999999995 110.934 -179.946 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 8.3 mt -131.35 143.64 40.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.182 -0.463 . . . . 73.319999999999993 111.121 179.825 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -127.47 138.58 52.99 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.143 -0.48 . . . . 73.420000000000002 110.887 179.921 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 6.4 m-85 . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 116.142 -0.481 . . . . 75.349999999999994 110.862 -179.968 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.312 0 N-CA-C 112.515 -0.234 . . . . 62.140000000000001 112.515 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 9.2 m -100.34 154.6 18.36 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.828 0.346 . . . . 73.400000000000006 110.907 -179.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 6.9 p80 -133.03 143.32 49.31 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.193 -0.458 . . . . 72.219999999999999 110.86 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -86.01 107.87 17.98 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.211 -0.45 . . . . 72.450000000000003 110.958 -179.869 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -103.47 161.65 22.4 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-O 121.598 0.713 . . . . 60.329999999999998 111.129 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.74 -20.25 35.17 Favored 'Trans proline' 0 C--N 1.341 0.148 0 C-N-CA 122.71 2.273 . . . . 71.120000000000005 112.365 179.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 10.0 m-85 -96.68 -31.75 12.54 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.216 -0.447 . . . . 73.239999999999995 110.843 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 161.49 138.88 2.52 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.783 -0.722 . . . . 72.340000000000003 112.489 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -53.83 134.76 42.49 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.815 0.34 . . . . 72.129999999999995 110.914 -179.929 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 8.8 mt -131.37 143.51 40.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.222 -0.444 . . . . 72.409999999999997 111.125 179.827 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -127.88 141.81 51.45 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.167 -0.469 . . . . 74.319999999999993 110.884 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 5.8 m-85 . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 116.196 -0.456 . . . . 71.439999999999998 110.88 -179.959 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.28 0 N-CA-C 112.526 -0.23 . . . . 71.329999999999998 112.526 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 8.9 m -91.01 153.53 20.08 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.892 0.377 . . . . 72.010000000000005 110.875 -179.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 6.8 p80 -133.18 141.99 48.39 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.154 -0.476 . . . . 74.409999999999997 110.884 179.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -84.93 107.4 17.05 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.203 -0.453 . . . . 74.099999999999994 110.913 -179.871 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.403 ' HB ' ' HD2' ' A' ' 6' ' ' PRO . 0.1 OUTLIER -102.96 161.6 22.63 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.584 0.707 . . . . 72.140000000000001 111.122 -179.981 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.403 ' HD2' ' HB ' ' A' ' 5' ' ' THR . 53.2 Cg_endo -69.76 -19.93 35.5 Favored 'Trans proline' 0 C--O 1.232 0.181 0 C-N-CA 122.685 2.256 . . . . 72.439999999999998 112.339 179.946 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 10.2 m-85 -96.96 -31.5 12.51 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.198 -0.455 . . . . 73.530000000000001 110.863 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 161.52 138.63 2.46 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.696 -0.764 . . . . 71.409999999999997 112.487 -179.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -53.85 134.66 42.61 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.788 0.328 . . . . 75.430000000000007 110.941 -179.949 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 8.8 mt -131.46 143.65 39.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.205 -0.452 . . . . 71.439999999999998 111.116 179.877 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -127.25 132.83 50.29 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.203 -0.453 . . . . 72.519999999999996 110.891 179.935 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 7.4 m-85 . . . . . 0 C--N 1.329 -0.326 0 CA-C-N 116.186 -0.461 . . . . 74.120000000000005 110.859 -179.935 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.309 0 N-CA-C 112.491 -0.244 . . . . 65.540000000000006 112.491 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 11.3 m -109.34 156.61 19.78 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.849 0.357 . . . . 65.109999999999999 110.854 -179.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 7.7 p80 -130.66 140.5 50.39 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.16 -0.473 . . . . 71.319999999999993 110.844 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -82.73 110.62 17.93 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.212 -0.449 . . . . 74.120000000000005 110.928 -179.867 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.401 ' HB ' ' HD2' ' A' ' 6' ' ' PRO . 0.0 OUTLIER -106.77 161.64 22.24 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.583 0.706 . . . . 71.219999999999999 111.136 -179.96 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.401 ' HD2' ' HB ' ' A' ' 5' ' ' THR . 53.6 Cg_endo -69.77 -19.45 36.05 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.691 2.261 . . . . 73.049999999999997 112.314 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 10.1 m-85 -97.75 -31.78 12.07 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.202 -0.454 . . . . 73.439999999999998 110.887 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 161.37 138.71 2.48 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.722 -0.751 . . . . 74.519999999999996 112.488 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -53.75 133.82 42.15 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.79 0.329 . . . . 75.519999999999996 110.941 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 7.5 mt -131.39 143.95 39.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.198 -0.456 . . . . 75.319999999999993 111.173 179.825 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -123.03 152.93 40.49 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.16 -0.473 . . . . 71.340000000000003 110.889 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 4.7 p90 . . . . . 0 C--N 1.329 -0.323 0 CA-C-N 116.196 -0.456 . . . . 65.230000000000004 110.905 -179.979 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.358 0 N-CA-C 112.538 -0.225 . . . . 62.329999999999998 112.538 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 11.4 m -107.7 156.43 19.1 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.885 0.374 . . . . 74.510000000000005 110.863 -179.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 7.7 p80 -130.42 140.57 50.57 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.147 -0.479 . . . . 74.319999999999993 110.898 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -82.8 110.71 18.06 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.227 -0.442 . . . . 71.319999999999993 110.9 -179.846 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.402 ' HB ' ' HD2' ' A' ' 6' ' ' PRO . 0.0 OUTLIER -106.91 161.67 22.16 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-O 121.558 0.695 . . . . 73.129999999999995 111.14 -179.981 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.402 ' HD2' ' HB ' ' A' ' 5' ' ' THR . 53.1 Cg_endo -69.81 -19.41 35.94 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.682 2.254 . . . . 75.030000000000001 112.309 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 10.0 m-85 -97.7 -31.89 12.03 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.224 -0.444 . . . . 73.140000000000001 110.892 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 161.42 138.72 2.49 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.731 -0.747 . . . . 75.409999999999997 112.51 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -53.81 133.99 42.45 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.842 0.353 . . . . 63.200000000000003 110.865 -179.88 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 7.5 mt -131.44 143.92 39.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.175 -0.466 . . . . 75.129999999999995 111.105 179.866 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -123.11 152.79 40.75 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.184 -0.462 . . . . 74.099999999999994 110.915 179.885 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 4.8 p90 . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.151 -0.477 . . . . 74.329999999999998 110.84 -179.941 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.319 0 N-CA-C 112.504 -0.238 . . . . 70.209999999999994 112.504 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 9.9 m -100.81 154.7 18.42 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.854 0.359 . . . . 72.340000000000003 110.887 -179.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 7.3 p80 -132.9 141.25 48.28 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.184 -0.462 . . . . 74.010000000000005 110.874 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -84.97 106.45 16.48 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.185 -0.462 . . . . 72.329999999999998 110.871 -179.82 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.426 ' HB ' ' HD2' ' A' ' 6' ' ' PRO . 0.1 OUTLIER -102.84 161.24 23.77 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.594 0.711 . . . . 74.340000000000003 111.15 179.982 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.426 ' HD2' ' HB ' ' A' ' 5' ' ' THR . 53.7 Cg_endo -69.81 -18.2 36.91 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.707 2.271 . . . . 74.099999999999994 112.316 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 13.8 m-85 -97.64 -31.34 12.34 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.201 -0.454 . . . . 73.200000000000003 110.856 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 160.2 138.04 2.35 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.755 -0.736 . . . . 52.229999999999997 112.47 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -53.86 133.48 42.72 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.812 0.339 . . . . 74.430000000000007 110.863 -179.88 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 8.3 mt -131.4 143.51 40.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.165 -0.47 . . . . 72.510000000000005 111.116 179.85 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -126.62 142.51 51.51 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.193 -0.458 . . . . 74.019999999999996 110.884 179.904 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 . . . . . 0 C--N 1.329 -0.323 0 CA-C-N 116.18 -0.464 . . . . 72.140000000000001 110.868 -179.923 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.318 0 N-CA-C 112.477 -0.249 . . . . 55.409999999999997 112.477 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 9.3 m -95.08 153.63 17.55 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.857 0.361 . . . . 53.310000000000002 110.874 -179.89 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 7.8 p80 -132.99 144.79 50.33 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.186 -0.461 . . . . 71.109999999999999 110.874 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -87.55 111.14 20.91 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.272 -0.422 . . . . 70.510000000000005 110.895 -179.827 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.406 ' HB ' ' HD2' ' A' ' 6' ' ' PRO . 0.1 OUTLIER -107.92 161.45 23.25 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-O 121.593 0.711 . . . . 73.239999999999995 111.14 -179.971 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.406 ' HD2' ' HB ' ' A' ' 5' ' ' THR . 53.5 Cg_endo -69.8 -18.71 36.66 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.646 2.23 . . . . 64.510000000000005 112.301 -180.0 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 11.9 m-85 -97.61 -31.32 12.36 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.238 -0.437 . . . . 74.530000000000001 110.837 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 159.99 138.02 2.35 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.748 -0.739 . . . . 74.409999999999997 112.48 -179.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -53.96 134.45 43.26 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.749 0.309 . . . . 75.540000000000006 110.874 -179.913 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 14.5 mt -131.34 142.73 42.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.176 -0.466 . . . . 71.420000000000002 111.142 179.799 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -126.64 144.19 50.98 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.14 -0.482 . . . . 75.299999999999997 110.857 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 6.7 m-85 . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 116.167 -0.469 . . . . 72.0 110.911 179.996 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.279 0 N-CA-C 112.477 -0.249 . . . . 45.399999999999999 112.477 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 11.4 m -104.33 156.56 17.81 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.832 0.349 . . . . 75.519999999999996 110.935 -179.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 7.6 p80 -130.28 139.77 50.72 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.214 -0.448 . . . . 74.25 110.828 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -82.15 110.0 16.96 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.222 -0.444 . . . . 74.120000000000005 110.905 -179.824 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.404 ' HB ' ' HD2' ' A' ' 6' ' ' PRO . 0.0 OUTLIER -106.17 161.67 22.13 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 121.549 0.69 . . . . 73.329999999999998 111.16 -179.973 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.404 ' HD2' ' HB ' ' A' ' 5' ' ' THR . 53.7 Cg_endo -69.79 -19.53 35.87 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.665 2.243 . . . . 73.549999999999997 112.337 179.957 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 10.1 m-85 -97.53 -31.86 12.11 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.246 -0.434 . . . . 75.420000000000002 110.859 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 161.46 138.71 2.48 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.789 -0.719 . . . . 45.140000000000001 112.479 -179.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -53.73 133.72 42.03 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.769 0.319 . . . . 74.219999999999999 110.92 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 7.4 mt -131.4 144.03 38.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.154 -0.475 . . . . 74.530000000000001 111.151 179.836 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -122.92 153.82 39.18 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.202 -0.454 . . . . 71.319999999999993 110.876 179.924 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 4.8 p90 . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 116.147 -0.479 . . . . 73.049999999999997 110.945 179.979 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.302 0 N-CA-C 112.442 -0.263 . . . . 72.219999999999999 112.442 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 11.9 m -96.3 156.85 16.17 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.866 0.365 . . . . 71.230000000000004 110.875 -179.885 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 7.7 p80 -130.36 138.6 50.48 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.167 -0.47 . . . . 74.209999999999994 110.836 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -81.22 110.23 16.5 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.216 -0.447 . . . . 74.230000000000004 110.923 -179.84 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.406 ' HB ' ' HD2' ' A' ' 6' ' ' PRO . 0.0 OUTLIER -106.54 161.65 22.19 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-O 121.582 0.705 . . . . 52.200000000000003 111.13 -179.962 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.406 ' HD2' ' HB ' ' A' ' 5' ' ' THR . 54.0 Cg_endo -69.74 -19.54 36.1 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.699 2.266 . . . . 75.340000000000003 112.349 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 10.3 m-85 -97.56 -31.63 12.22 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.204 -0.453 . . . . 72.5 110.847 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 161.16 138.74 2.49 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.774 -0.726 . . . . 65.239999999999995 112.506 -179.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -53.73 133.83 42.04 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.777 0.322 . . . . 70.450000000000003 110.92 -179.94 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 7.4 mt -131.49 144.0 38.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.202 -0.453 . . . . 73.540000000000006 111.147 179.852 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -123.02 153.55 39.66 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.212 -0.449 . . . . 74.409999999999997 110.915 179.915 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 4.8 p90 . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.169 -0.469 . . . . 73.430000000000007 110.903 -179.978 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.303 0 N-CA-C 112.487 -0.245 . . . . 71.049999999999997 112.487 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 11.1 m -96.83 157.08 16.07 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.887 0.375 . . . . 74.329999999999998 110.878 -179.885 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 7.5 p80 -130.58 138.42 50.14 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.207 -0.452 . . . . 72.120000000000005 110.83 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -81.14 109.48 15.73 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.177 -0.465 . . . . 75.129999999999995 110.915 -179.856 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.408 ' HB ' ' HD2' ' A' ' 6' ' ' PRO . 0.0 OUTLIER -105.57 161.6 22.31 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.588 0.709 . . . . 71.340000000000003 111.137 -179.964 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.408 ' HD2' ' HB ' ' A' ' 5' ' ' THR . 53.8 Cg_endo -69.78 -19.49 35.96 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.698 2.265 . . . . 71.450000000000003 112.323 179.962 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 10.2 m-85 -97.52 -31.81 12.14 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.238 -0.437 . . . . 73.230000000000004 110.844 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 161.45 138.69 2.48 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.756 -0.735 . . . . 75.329999999999998 112.481 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -53.73 133.63 42.06 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.808 0.337 . . . . 72.400000000000006 110.881 -179.902 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 7.4 mt -131.4 144.11 38.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.174 -0.466 . . . . 75.129999999999995 111.166 179.818 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -123.08 153.56 39.74 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.219 -0.446 . . . . 72.120000000000005 110.9 179.937 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 4.9 p90 . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 116.212 -0.449 . . . . 74.150000000000006 110.942 179.986 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.363 0 N-CA-C 112.512 -0.235 . . . . 64.31 112.512 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 9.9 m -105.14 154.68 19.85 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.851 0.358 . . . . 72.52 110.847 -179.874 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' HIS . . . . . 0.415 ' O ' HD23 ' A' ' 9' ' ' LEU . 6.9 p80 -133.06 141.99 48.52 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.159 -0.473 . . . . 74.35 110.853 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -85.05 107.58 17.23 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.203 -0.453 . . . . 72.3 110.937 -179.837 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.828 HG21 HD12 ' A' ' 10' ' ' ILE . 0.0 OUTLIER -103.16 161.56 22.74 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.606 0.717 . . . . 70.11 111.158 -179.968 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.42 ' HD2' ' HB ' ' A' ' 5' ' ' THR . 54.0 Cg_endo -69.73 -19.88 35.67 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.673 2.249 . . . . 75.12 112.344 179.931 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 10.2 m-85 -97.04 -31.7 12.37 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.198 -0.455 . . . . 75.52 110.841 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 161.63 138.62 2.46 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.736 -0.745 . . . . 52.24 112.489 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.415 HD23 ' O ' ' A' ' 3' ' ' HIS . 0.6 OUTLIER -53.85 134.63 42.62 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.773 0.32 . . . . 53.1 110.897 -179.916 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.828 HD12 HG21 ' A' ' 5' ' ' THR . 8.2 mt -131.39 143.58 40.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.251 -0.431 . . . . 72.1 111.136 179.828 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -127.78 143.98 51.11 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.167 -0.47 . . . . 65.24 110.855 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 6.7 m-85 . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 116.131 -0.486 . . . . 74.13 110.87 -179.957 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.335 0 N-CA-C 112.492 -0.243 . . . . 72.31 112.492 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 10.1 m -96.27 154.68 17.12 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.862 0.363 . . . . 74.43 110.846 -179.87 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' HIS . . . . . 0.412 ' O ' HD23 ' A' ' 9' ' ' LEU . 6.9 p80 -133.0 141.41 48.27 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.151 -0.477 . . . . 71.44 110.857 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -84.63 107.41 16.83 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.227 -0.442 . . . . 70.31 110.865 -179.841 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.838 HG21 HD12 ' A' ' 10' ' ' ILE . 0.1 OUTLIER -102.97 161.52 22.87 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.617 0.723 . . . . 71.11 111.125 -179.989 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.425 ' HD2' ' HB ' ' A' ' 5' ' ' THR . 54.6 Cg_endo -69.74 -19.74 35.84 Favored 'Trans proline' 0 C--O 1.231 0.16 0 C-N-CA 122.716 2.278 . . . . 62.35 112.372 179.916 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 10.3 m-85 -97.1 -31.7 12.34 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.213 -0.448 . . . . 73.51 110.848 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 161.63 138.56 2.45 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.766 -0.73 . . . . 63.51 112.49 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.412 HD23 ' O ' ' A' ' 3' ' ' HIS . 0.7 OUTLIER -53.85 134.48 42.65 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.749 0.309 . . . . 73.45 110.895 -179.92 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.838 HD12 HG21 ' A' ' 5' ' ' THR . 7.9 mt -131.32 143.51 40.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.169 -0.468 . . . . 73.03 111.149 179.836 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -127.65 145.33 50.92 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.18 -0.463 . . . . 70.24 110.847 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 6.5 m-85 . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.149 -0.478 . . . . 74.23 110.866 179.997 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.336 0 N-CA-C 112.494 -0.243 . . . . 74.3 112.494 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 9.9 m -102.14 154.58 18.88 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.805 0.336 . . . . 73.55 110.927 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' HIS . . . . . 0.415 ' O ' HD23 ' A' ' 9' ' ' LEU . 6.9 p80 -132.99 141.93 48.57 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.218 -0.446 . . . . 71.33 110.886 179.915 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -84.95 107.77 17.25 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.205 -0.452 . . . . 65.1 110.946 -179.862 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.827 HG21 HD12 ' A' ' 10' ' ' ILE . 0.0 OUTLIER -103.32 161.57 22.66 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.569 0.699 . . . . 73.12 111.108 -179.933 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.421 ' HD2' ' HB ' ' A' ' 5' ' ' THR . 53.7 Cg_endo -69.77 -19.87 35.51 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.656 2.238 . . . . 74.14 112.376 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 10.1 m-85 -97.06 -31.66 12.38 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.172 -0.467 . . . . 63.3 110.883 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 161.62 138.63 2.46 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.761 -0.733 . . . . 73.44 112.492 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.415 HD23 ' O ' ' A' ' 3' ' ' HIS . 0.6 OUTLIER -53.92 134.63 43.0 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.832 0.348 . . . . 73.33 110.931 -179.907 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.827 HD12 HG21 ' A' ' 5' ' ' THR . 8.2 mt -131.38 143.55 40.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.187 -0.461 . . . . 72.33 111.143 179.863 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -127.65 144.74 51.05 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.157 -0.474 . . . . 74.12 110.848 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 6.0 m-85 . . . . . 0 C--N 1.329 -0.315 0 CA-C-N 116.142 -0.481 . . . . 64.45 110.932 -179.992 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.369 0 N-CA-C 112.47 -0.252 . . . . 74.22 112.47 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 9.7 m -95.45 154.47 17.19 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.876 0.37 . . . . 63.22 110.864 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' HIS . . . . . 0.415 ' O ' HD23 ' A' ' 9' ' ' LEU . 6.9 p80 -132.76 141.82 48.71 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.191 -0.459 . . . . 63.2 110.887 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -84.94 107.4 17.06 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.194 -0.457 . . . . 73.42 110.889 -179.801 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.844 HG21 HD12 ' A' ' 10' ' ' ILE . 0.1 OUTLIER -102.95 161.52 22.88 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.535 0.683 . . . . 74.03 111.165 -179.995 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.425 ' HD2' ' HB ' ' A' ' 5' ' ' THR . 53.3 Cg_endo -69.83 -19.67 35.48 Favored 'Trans proline' 0 N--CA 1.465 -0.161 0 C-N-CA 122.694 2.263 . . . . 74.44 112.338 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 10.4 m-85 -97.13 -31.65 12.36 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.186 -0.461 . . . . 73.12 110.899 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 161.5 138.48 2.43 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.788 -0.72 . . . . 61.05 112.54 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.415 HD23 ' O ' ' A' ' 3' ' ' HIS . 0.7 OUTLIER -53.79 134.5 42.3 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.794 0.331 . . . . 51.23 110.93 -179.905 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.844 HD12 HG21 ' A' ' 5' ' ' THR . 7.8 mt -131.35 143.63 40.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.187 -0.461 . . . . 63.23 111.085 179.887 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -127.7 145.49 50.88 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.159 -0.473 . . . . 73.33 110.877 179.95 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 7.2 m-85 . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.2 -0.454 . . . . 71.21 110.865 -179.947 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.342 0 N-CA-C 112.51 -0.236 . . . . 63.03 112.51 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 9.8 m -104.46 154.37 19.96 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.877 0.37 . . . . 62.35 110.901 -179.879 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 6.9 p80 -133.03 142.6 48.89 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.178 -0.465 . . . . 75.22 110.839 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -85.66 107.57 17.61 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.255 -0.429 . . . . 75.52 110.922 -179.855 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.837 HG21 HD12 ' A' ' 10' ' ' ILE . 0.1 OUTLIER -103.14 161.57 22.69 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.616 0.722 . . . . 74.12 111.102 -179.943 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.423 ' HD2' ' HB ' ' A' ' 5' ' ' THR . 53.8 Cg_endo -69.8 -19.62 35.68 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.683 2.256 . . . . 64.14 112.319 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 10.3 m-85 -97.17 -31.67 12.34 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.226 -0.443 . . . . 65.44 110.87 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 161.5 138.6 2.46 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.796 -0.716 . . . . 60.25 112.507 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -53.84 134.52 42.56 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.796 0.331 . . . . 71.41 110.924 -179.943 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.837 HD12 HG21 ' A' ' 5' ' ' THR . 7.9 mt -131.32 143.63 40.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.177 -0.465 . . . . 75.02 111.14 179.833 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -127.85 145.33 50.97 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.137 -0.483 . . . . 64.24 110.884 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 7.6 m-85 . . . . . 0 C--N 1.328 -0.348 0 CA-C-N 116.156 -0.475 . . . . 74.13 110.896 -179.98 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.33 0 N-CA-C 112.503 -0.239 . . . . 33.32 112.503 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 9.5 m -103.59 154.43 19.5 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.887 0.375 . . . . 71.41 110.867 -179.892 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' HIS . . . . . 0.419 ' O ' HD23 ' A' ' 9' ' ' LEU . 6.9 p80 -132.59 141.71 48.81 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.13 -0.486 . . . . 52.32 110.834 179.913 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -84.72 107.62 17.01 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.178 -0.465 . . . . 64.1 110.915 -179.833 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.832 HG21 HD12 ' A' ' 10' ' ' ILE . 0.1 OUTLIER -103.23 161.58 22.65 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.629 0.728 . . . . 41.41 111.13 -179.987 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.422 ' HD2' ' HB ' ' A' ' 5' ' ' THR . 53.3 Cg_endo -69.74 -19.88 35.65 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.731 2.288 . . . . 61.1 112.322 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 10.1 m-85 -97.0 -31.84 12.31 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.231 -0.44 . . . . 72.02 110.89 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 161.66 138.57 2.45 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.732 -0.747 . . . . 13.52 112.48 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.419 HD23 ' O ' ' A' ' 3' ' ' HIS . 0.7 OUTLIER -53.79 134.55 42.31 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.815 0.341 . . . . 74.24 110.892 -179.927 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.832 HD12 HG21 ' A' ' 5' ' ' THR . 8.0 mt -131.32 143.57 40.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.218 -0.446 . . . . 61.34 111.109 179.81 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -127.5 144.56 51.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.147 -0.479 . . . . 64.22 110.872 179.885 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 116.18 -0.464 . . . . 64.44 110.84 -179.956 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.357 0 N-CA-C 112.478 -0.249 . . . . 73.02 112.478 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 9.5 m -91.76 154.36 18.99 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.896 0.379 . . . . 74.1 110.903 -179.924 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 6.9 p80 -132.97 142.47 48.88 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.19 -0.459 . . . . 60.13 110.856 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -85.53 107.47 17.48 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.224 -0.443 . . . . 65.01 110.906 -179.846 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.845 HG21 HD12 ' A' ' 10' ' ' ILE . 0.1 OUTLIER -103.02 161.59 22.65 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-O 121.604 0.716 . . . . 75.42 111.122 -179.967 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.426 ' HD2' ' HB ' ' A' ' 5' ' ' THR . 53.3 Cg_endo -69.79 -19.77 35.54 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.731 2.287 . . . . 73.01 112.313 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 10.3 m-85 -97.06 -31.63 12.39 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.19 -0.459 . . . . 73.45 110.876 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 161.44 138.6 2.46 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.736 -0.745 . . . . 54.44 112.469 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -53.78 134.55 42.23 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.826 0.346 . . . . 75.43 110.919 -179.929 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.845 HD12 HG21 ' A' ' 5' ' ' THR . 7.9 mt -131.36 143.56 40.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.137 -0.483 . . . . 72.54 111.116 179.843 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -127.85 144.4 51.09 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.2 -0.454 . . . . 72.21 110.859 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 7.2 m-85 . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 116.167 -0.469 . . . . 70.5 110.878 -179.947 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.335 0 N-CA-C 112.44 -0.264 . . . . 70.42 112.44 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 9.6 m -100.2 154.71 18.23 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.91 0.386 . . . . 73.13 110.889 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 6.9 p80 -133.1 141.52 48.23 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.163 -0.471 . . . . 72.32 110.829 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -84.66 107.48 16.89 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.208 -0.451 . . . . 72.05 110.888 -179.844 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.833 HG21 HD12 ' A' ' 10' ' ' ILE . 0.1 OUTLIER -103.05 161.56 22.73 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.6 0.714 . . . . 71.42 111.135 179.989 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.423 ' HD2' ' HB ' ' A' ' 5' ' ' THR . 53.9 Cg_endo -69.82 -19.74 35.44 Favored 'Trans proline' 0 C--O 1.231 0.17 0 C-N-CA 122.704 2.27 . . . . 74.5 112.324 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 10.3 m-85 -97.1 -31.63 12.38 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.229 -0.441 . . . . 64.53 110.862 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 161.56 138.57 2.45 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.77 -0.729 . . . . 75.15 112.529 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -53.87 134.59 42.75 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.826 0.345 . . . . 74.32 110.893 -179.918 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.833 HD12 HG21 ' A' ' 5' ' ' THR . 8.0 mt -131.37 143.4 40.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.156 -0.474 . . . . 73.41 111.141 179.861 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -127.76 144.03 51.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.178 -0.464 . . . . 70.41 110.872 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 6.9 m-85 . . . . . 0 C--N 1.328 -0.33 0 CA-C-N 116.196 -0.456 . . . . 62.21 110.877 -179.968 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.302 0 N-CA-C 112.495 -0.242 . . . . 54.33 112.495 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 9.7 m -102.57 154.71 18.86 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.852 0.358 . . . . 63.42 110.901 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 6.9 p80 -133.04 141.85 48.46 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.212 -0.449 . . . . 61.44 110.887 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -84.98 107.53 17.15 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.195 -0.457 . . . . 75.14 110.927 -179.85 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.834 HG21 HD12 ' A' ' 10' ' ' ILE . 0.1 OUTLIER -103.12 161.56 22.74 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.55 0.69 . . . . 63.03 111.13 -179.97 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.424 ' HD2' ' HB ' ' A' ' 5' ' ' THR . 53.7 Cg_endo -69.75 -19.64 35.92 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.633 2.222 . . . . 72.04 112.336 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 10.4 m-85 -97.16 -31.76 12.3 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.221 -0.445 . . . . 75.01 110.894 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 161.64 138.67 2.47 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.737 -0.744 . . . . 60.13 112.483 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -53.88 134.54 42.81 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.764 0.316 . . . . 74.12 110.879 -179.91 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.834 HD12 HG21 ' A' ' 5' ' ' THR . 8.0 mt -131.42 143.67 39.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.187 -0.461 . . . . 74.41 111.16 179.815 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -127.67 139.1 52.92 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.186 -0.461 . . . . 73.02 110.86 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 6.2 m-85 . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.14 -0.482 . . . . 71.41 110.877 179.999 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.325 0 N-CA-C 112.469 -0.252 . . . . 72.44 112.469 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 9.5 m -96.04 154.42 17.25 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.87 0.367 . . . . 74.41 110.885 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 6.9 p80 -133.01 142.82 49.03 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.204 -0.453 . . . . 75.44 110.909 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -85.79 107.79 17.8 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.215 -0.448 . . . . 64.13 110.907 -179.822 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.819 HG21 HD12 ' A' ' 10' ' ' ILE . 0.0 OUTLIER -103.29 161.62 22.53 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.588 0.709 . . . . 74.34 111.14 -179.997 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.419 ' HD2' ' HB ' ' A' ' 5' ' ' THR . 53.2 Cg_endo -69.84 -19.55 35.58 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.665 2.243 . . . . 72.42 112.316 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 10.3 m-85 -97.33 -31.8 12.21 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.24 -0.436 . . . . 74.14 110.846 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 161.68 138.75 2.49 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.768 -0.73 . . . . 54.53 112.491 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -53.84 134.64 42.56 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.77 0.319 . . . . 73.44 110.933 -179.912 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.819 HD12 HG21 ' A' ' 5' ' ' THR . 8.8 mt -131.31 143.44 40.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.193 -0.458 . . . . 62.41 111.112 179.841 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -127.89 145.1 51.06 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.207 -0.451 . . . . 61.05 110.874 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 . . . . . 0 C--N 1.33 -0.263 0 CA-C-N 116.168 -0.469 . . . . 62.1 110.882 -179.965 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.301 0 N-CA-C 112.533 -0.227 . . . . 62.33 112.533 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 9.8 m -99.87 154.7 18.14 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.829 0.347 . . . . 64.3 110.888 -179.898 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 6.9 p80 -133.03 142.36 48.76 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.188 -0.46 . . . . 74.14 110.863 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -85.38 107.75 17.51 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.25 -0.432 . . . . 63.54 110.973 -179.89 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.826 HG21 HD12 ' A' ' 10' ' ' ILE . 0.1 OUTLIER -103.32 161.55 22.72 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.619 0.723 . . . . 61.42 111.12 -179.942 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.422 ' HD2' ' HB ' ' A' ' 5' ' ' THR . 53.8 Cg_endo -69.72 -19.49 36.26 Favored 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.687 2.258 . . . . 64.03 112.342 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 10.4 m-85 -97.43 -31.84 12.16 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.218 -0.446 . . . . 72.33 110.855 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 161.72 138.64 2.47 Favored Glycine 0 N--CA 1.451 -0.367 0 C-N-CA 120.757 -0.735 . . . . 52.22 112.479 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -53.82 134.53 42.47 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.808 0.337 . . . . 70.21 110.934 -179.946 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.826 HD12 HG21 ' A' ' 5' ' ' THR . 8.3 mt -131.35 143.64 40.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.182 -0.463 . . . . 72.53 111.121 179.825 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -127.47 138.58 52.99 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.143 -0.48 . . . . 62.51 110.887 179.921 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 6.4 m-85 . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 116.142 -0.481 . . . . 71.4 110.862 -179.968 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.312 0 N-CA-C 112.515 -0.234 . . . . 52.1 112.515 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 9.2 m -100.34 154.6 18.36 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.828 0.346 . . . . 73.12 110.907 -179.916 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 6.9 p80 -133.03 143.32 49.31 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.193 -0.458 . . . . 72.13 110.86 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -86.01 107.87 17.98 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.211 -0.45 . . . . 72.45 110.958 -179.869 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.824 HG21 HD12 ' A' ' 10' ' ' ILE . 0.0 OUTLIER -103.47 161.65 22.4 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-O 121.598 0.713 . . . . 53.42 111.129 -179.962 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.422 ' HD2' ' HB ' ' A' ' 5' ' ' THR . 54.2 Cg_endo -69.74 -20.25 35.17 Favored 'Trans proline' 0 C--N 1.341 0.148 0 C-N-CA 122.71 2.273 . . . . 71.12 112.365 179.883 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 10.0 m-85 -96.68 -31.75 12.54 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.216 -0.447 . . . . 62.05 110.843 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 161.49 138.88 2.52 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.783 -0.722 . . . . 62.01 112.489 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -53.83 134.76 42.49 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.815 0.34 . . . . 71.23 110.914 -179.929 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.824 HD12 HG21 ' A' ' 5' ' ' THR . 8.8 mt -131.37 143.51 40.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.222 -0.444 . . . . 72.41 111.125 179.827 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -127.88 141.81 51.45 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.167 -0.469 . . . . 74.14 110.884 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 5.8 m-85 . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 116.196 -0.456 . . . . 53.23 110.88 -179.959 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.28 0 N-CA-C 112.526 -0.23 . . . . 64.41 112.526 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 8.9 m -91.01 153.53 20.08 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.892 0.377 . . . . 65.35 110.875 -179.923 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 6.8 p80 -133.18 141.99 48.39 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.154 -0.476 . . . . 70.42 110.884 179.935 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -84.93 107.4 17.05 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.203 -0.453 . . . . 74.1 110.913 -179.871 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.828 HG21 HD12 ' A' ' 10' ' ' ILE . 0.1 OUTLIER -102.96 161.6 22.63 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.584 0.707 . . . . 72.14 111.122 -179.981 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.424 ' HD2' ' HB ' ' A' ' 5' ' ' THR . 53.2 Cg_endo -69.76 -19.93 35.5 Favored 'Trans proline' 0 C--O 1.232 0.181 0 C-N-CA 122.685 2.256 . . . . 72.44 112.339 179.946 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 10.2 m-85 -96.96 -31.5 12.51 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.198 -0.455 . . . . 73.53 110.863 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 161.52 138.63 2.46 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.696 -0.764 . . . . 32.12 112.487 -179.899 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -53.85 134.66 42.61 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.788 0.328 . . . . 72.22 110.941 -179.949 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.828 HD12 HG21 ' A' ' 5' ' ' THR . 8.8 mt -131.46 143.65 39.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.205 -0.452 . . . . 71.44 111.116 179.877 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -127.25 132.83 50.29 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.203 -0.453 . . . . 72.52 110.891 179.935 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 7.4 m-85 . . . . . 0 C--N 1.329 -0.326 0 CA-C-N 116.186 -0.461 . . . . 53.43 110.859 -179.935 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.309 0 N-CA-C 112.491 -0.244 . . . . 65.54 112.491 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 11.3 m -109.34 156.61 19.78 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.849 0.357 . . . . 54.12 110.854 -179.888 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 7.7 p80 -130.66 140.5 50.39 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.16 -0.473 . . . . 71.32 110.844 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -82.73 110.62 17.93 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.212 -0.449 . . . . 74.12 110.928 -179.867 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.841 HG21 HD12 ' A' ' 10' ' ' ILE . 0.0 OUTLIER -106.77 161.64 22.24 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.583 0.706 . . . . 71.22 111.136 -179.96 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.422 ' HD2' ' HB ' ' A' ' 5' ' ' THR . 53.6 Cg_endo -69.77 -19.45 36.05 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.691 2.261 . . . . 73.05 112.314 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 10.1 m-85 -97.75 -31.78 12.07 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.202 -0.454 . . . . 54.4 110.887 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 161.37 138.71 2.48 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.722 -0.751 . . . . 72.02 112.488 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -53.75 133.82 42.15 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.79 0.329 . . . . 65.01 110.941 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.841 HD12 HG21 ' A' ' 5' ' ' THR . 7.5 mt -131.39 143.95 39.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.198 -0.456 . . . . 71.33 111.173 179.825 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -123.03 152.93 40.49 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.16 -0.473 . . . . 45.04 110.889 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 4.7 p90 . . . . . 0 C--N 1.329 -0.323 0 CA-C-N 116.196 -0.456 . . . . 65.23 110.905 -179.979 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.358 0 N-CA-C 112.538 -0.225 . . . . 62.33 112.538 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 11.4 m -107.7 156.43 19.1 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.885 0.374 . . . . 74.51 110.863 -179.918 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 7.7 p80 -130.42 140.57 50.57 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.147 -0.479 . . . . 73.34 110.898 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -82.8 110.71 18.06 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.227 -0.442 . . . . 65.15 110.9 -179.846 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.844 HG21 HD12 ' A' ' 10' ' ' ILE . 0.0 OUTLIER -106.91 161.67 22.16 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-O 121.558 0.695 . . . . 64.22 111.14 -179.981 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.423 ' HD2' ' HB ' ' A' ' 5' ' ' THR . 53.1 Cg_endo -69.81 -19.41 35.94 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.682 2.254 . . . . 61.5 112.309 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 10.0 m-85 -97.7 -31.89 12.03 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.224 -0.444 . . . . 64.4 110.892 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 161.42 138.72 2.49 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.731 -0.747 . . . . 70.11 112.51 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -53.81 133.99 42.45 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.842 0.353 . . . . 53.01 110.865 -179.88 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.844 HD12 HG21 ' A' ' 5' ' ' THR . 7.5 mt -131.44 143.92 39.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.175 -0.466 . . . . 72.22 111.105 179.866 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -123.11 152.79 40.75 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.184 -0.462 . . . . 71.33 110.915 179.885 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 4.8 p90 . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.151 -0.477 . . . . 71.52 110.84 -179.941 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.319 0 N-CA-C 112.504 -0.238 . . . . 65.03 112.504 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 9.9 m -100.81 154.7 18.42 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.854 0.359 . . . . 72.34 110.887 -179.896 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 7.3 p80 -132.9 141.25 48.28 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.184 -0.462 . . . . 65.32 110.874 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -84.97 106.45 16.48 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.185 -0.462 . . . . 72.33 110.871 -179.82 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.687 HG21 HD12 ' A' ' 10' ' ' ILE . 0.1 OUTLIER -102.84 161.24 23.77 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.594 0.711 . . . . 73.34 111.15 179.982 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.447 ' HD2' ' HB ' ' A' ' 5' ' ' THR . 53.7 Cg_endo -69.81 -18.2 36.91 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.707 2.271 . . . . 71.12 112.316 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 13.8 m-85 -97.64 -31.34 12.34 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.201 -0.454 . . . . 73.2 110.856 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 160.2 138.04 2.35 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.755 -0.736 . . . . 51.42 112.47 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -53.86 133.48 42.72 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.812 0.339 . . . . 74.43 110.863 -179.88 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.687 HD12 HG21 ' A' ' 5' ' ' THR . 8.3 mt -131.4 143.51 40.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.165 -0.47 . . . . 70.45 111.116 179.85 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -126.62 142.51 51.51 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.193 -0.458 . . . . 74.02 110.884 179.904 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 . . . . . 0 C--N 1.329 -0.323 0 CA-C-N 116.18 -0.464 . . . . 72.14 110.868 -179.923 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.318 0 N-CA-C 112.477 -0.249 . . . . 54.32 112.477 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 9.3 m -95.08 153.63 17.55 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.857 0.361 . . . . 53.31 110.874 -179.89 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' HIS . . . . . 0.541 ' O ' HD23 ' A' ' 9' ' ' LEU . 7.8 p80 -132.99 144.79 50.33 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.186 -0.461 . . . . 54.43 110.874 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -87.55 111.14 20.91 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.272 -0.422 . . . . 70.51 110.895 -179.827 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.55 HG21 HD12 ' A' ' 10' ' ' ILE . 0.1 OUTLIER -107.92 161.45 23.25 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-O 121.593 0.711 . . . . 73.24 111.14 -179.971 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.43 ' HD2' ' HB ' ' A' ' 5' ' ' THR . 53.5 Cg_endo -69.8 -18.71 36.66 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.646 2.23 . . . . 64.51 112.301 -180.0 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 11.9 m-85 -97.61 -31.32 12.36 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.238 -0.437 . . . . 74.53 110.837 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 159.99 138.02 2.35 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.748 -0.739 . . . . 61.35 112.48 -179.933 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.541 HD23 ' O ' ' A' ' 3' ' ' HIS . 0.7 OUTLIER -53.96 134.45 43.26 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.749 0.309 . . . . 75.54 110.874 -179.913 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.55 HD12 HG21 ' A' ' 5' ' ' THR . 14.5 mt -131.34 142.73 42.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.176 -0.466 . . . . 64.14 111.142 179.799 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -126.64 144.19 50.98 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.14 -0.482 . . . . 72.15 110.857 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 6.7 m-85 . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 116.167 -0.469 . . . . 71.22 110.911 179.996 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.279 0 N-CA-C 112.477 -0.249 . . . . 40.12 112.477 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 11.4 m -104.33 156.56 17.81 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.832 0.349 . . . . 75.52 110.935 -179.947 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 7.6 p80 -130.28 139.77 50.72 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.214 -0.448 . . . . 74.25 110.828 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -82.15 110.0 16.96 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.222 -0.444 . . . . 71.2 110.905 -179.824 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.84 HG21 HD12 ' A' ' 10' ' ' ILE . 0.0 OUTLIER -106.17 161.67 22.13 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 121.549 0.69 . . . . 73.33 111.16 -179.973 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.424 ' HD2' ' HB ' ' A' ' 5' ' ' THR . 53.7 Cg_endo -69.79 -19.53 35.87 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.665 2.243 . . . . 60.43 112.337 179.957 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 10.1 m-85 -97.53 -31.86 12.11 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.246 -0.434 . . . . 72.51 110.859 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 161.46 138.71 2.48 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.789 -0.719 . . . . 45.14 112.479 -179.93 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -53.73 133.72 42.03 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.769 0.319 . . . . 52.42 110.92 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.84 HD12 HG21 ' A' ' 5' ' ' THR . 7.4 mt -131.4 144.03 38.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.154 -0.475 . . . . 62.54 111.151 179.836 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -122.92 153.82 39.18 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.202 -0.454 . . . . 42.54 110.876 179.924 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 4.8 p90 . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 116.147 -0.479 . . . . 62.22 110.945 179.979 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.302 0 N-CA-C 112.442 -0.263 . . . . 72.22 112.442 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 11.9 m -96.3 156.85 16.17 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.866 0.365 . . . . 71.23 110.875 -179.885 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 7.7 p80 -130.36 138.6 50.48 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.167 -0.47 . . . . 74.21 110.836 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -81.22 110.23 16.5 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.216 -0.447 . . . . 73.42 110.923 -179.84 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.842 HG21 HD12 ' A' ' 10' ' ' ILE . 0.0 OUTLIER -106.54 161.65 22.19 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-O 121.582 0.705 . . . . 52.2 111.13 -179.962 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.427 ' HD2' ' HB ' ' A' ' 5' ' ' THR . 54.0 Cg_endo -69.74 -19.54 36.1 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.699 2.266 . . . . 62.41 112.349 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 10.3 m-85 -97.56 -31.63 12.22 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.204 -0.453 . . . . 72.5 110.847 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 161.16 138.74 2.49 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.774 -0.726 . . . . 65.12 112.506 -179.951 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -53.73 133.83 42.04 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.777 0.322 . . . . 70.45 110.92 -179.94 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.842 HD12 HG21 ' A' ' 5' ' ' THR . 7.4 mt -131.49 144.0 38.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.202 -0.453 . . . . 44.41 111.147 179.852 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -123.02 153.55 39.66 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.212 -0.449 . . . . 74.41 110.915 179.915 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 4.8 p90 . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.169 -0.469 . . . . 61.44 110.903 -179.978 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.303 0 N-CA-C 112.487 -0.245 . . . . 71.05 112.487 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 11.1 m -96.83 157.08 16.07 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.887 0.375 . . . . 74.2 110.878 -179.885 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 7.5 p80 -130.58 138.42 50.14 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.207 -0.452 . . . . 72.12 110.83 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -81.14 109.48 15.73 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.177 -0.465 . . . . 70.04 110.915 -179.856 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.839 HG21 HD12 ' A' ' 10' ' ' ILE . 0.0 OUTLIER -105.57 161.6 22.31 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.588 0.709 . . . . 71.34 111.137 -179.964 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.431 ' HD2' ' HB ' ' A' ' 5' ' ' THR . 53.8 Cg_endo -69.78 -19.49 35.96 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.698 2.265 . . . . 71.45 112.323 179.962 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 10.2 m-85 -97.52 -31.81 12.14 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.238 -0.437 . . . . 64.54 110.844 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 161.45 138.69 2.48 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.756 -0.735 . . . . 70.41 112.481 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -53.73 133.63 42.06 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.808 0.337 . . . . 72.21 110.881 -179.902 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.839 HD12 HG21 ' A' ' 5' ' ' THR . 7.4 mt -131.4 144.11 38.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.174 -0.466 . . . . 51.11 111.166 179.818 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -123.08 153.56 39.74 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.219 -0.446 . . . . 45.23 110.9 179.937 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 4.9 p90 . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 116.212 -0.449 . . . . 74.15 110.942 179.986 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.363 0 N-CA-C 112.512 -0.235 . . . . 64.310000000000002 112.512 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 9.9 m -105.14 154.68 19.85 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.851 0.358 . . . . 72.519999999999996 110.847 -179.874 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . 0.415 ' O ' HD23 ' A' ' 9' ' ' LEU . 6.9 p80 -133.06 141.99 48.52 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.159 -0.473 . . . . 74.349999999999994 110.853 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -85.05 107.58 17.23 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.203 -0.453 . . . . 72.299999999999997 110.937 -179.837 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.828 HG21 HD12 ' A' ' 10' ' ' ILE . 0.0 OUTLIER -103.16 161.56 22.74 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.606 0.717 . . . . 70.109999999999999 111.158 -179.968 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.42 ' HD2' ' HB ' ' A' ' 5' ' ' THR . 54.0 Cg_endo -69.73 -19.88 35.67 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.673 2.249 . . . . 75.120000000000005 112.344 179.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 10.2 m-85 -97.04 -31.7 12.37 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.198 -0.455 . . . . 75.519999999999996 110.841 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 161.63 138.62 2.46 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.736 -0.745 . . . . 52.240000000000002 112.489 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.415 HD23 ' O ' ' A' ' 3' ' ' HIS . 0.6 OUTLIER -53.85 134.63 42.62 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.773 0.32 . . . . 53.100000000000001 110.897 -179.916 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.828 HD12 HG21 ' A' ' 5' ' ' THR . 8.2 mt -131.39 143.58 40.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.251 -0.431 . . . . 72.099999999999994 111.136 179.828 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -127.78 143.98 51.11 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.167 -0.47 . . . . 65.239999999999995 110.855 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 6.7 m-85 . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 116.131 -0.486 . . . . 74.129999999999995 110.87 -179.957 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.335 0 N-CA-C 112.492 -0.243 . . . . 72.310000000000002 112.492 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 10.1 m -96.27 154.68 17.12 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.862 0.363 . . . . 74.430000000000007 110.846 -179.87 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . 0.412 ' O ' HD23 ' A' ' 9' ' ' LEU . 6.9 p80 -133.0 141.41 48.27 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.151 -0.477 . . . . 71.439999999999998 110.857 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -84.63 107.41 16.83 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.227 -0.442 . . . . 70.310000000000002 110.865 -179.841 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.838 HG21 HD12 ' A' ' 10' ' ' ILE . 0.1 OUTLIER -102.97 161.52 22.87 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.617 0.723 . . . . 71.109999999999999 111.125 -179.989 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.425 ' HD2' ' HB ' ' A' ' 5' ' ' THR . 54.6 Cg_endo -69.74 -19.74 35.84 Favored 'Trans proline' 0 C--O 1.231 0.16 0 C-N-CA 122.716 2.278 . . . . 62.350000000000001 112.372 179.916 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 10.3 m-85 -97.1 -31.7 12.34 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.213 -0.448 . . . . 73.510000000000005 110.848 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 161.63 138.56 2.45 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.766 -0.73 . . . . 63.509999999999998 112.49 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.412 HD23 ' O ' ' A' ' 3' ' ' HIS . 0.7 OUTLIER -53.85 134.48 42.65 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.749 0.309 . . . . 73.450000000000003 110.895 -179.92 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.838 HD12 HG21 ' A' ' 5' ' ' THR . 7.9 mt -131.32 143.51 40.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.169 -0.468 . . . . 73.030000000000001 111.149 179.836 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -127.65 145.33 50.92 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.18 -0.463 . . . . 70.239999999999995 110.847 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 6.5 m-85 . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.149 -0.478 . . . . 74.230000000000004 110.866 179.997 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.336 0 N-CA-C 112.494 -0.243 . . . . 74.299999999999997 112.494 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 9.9 m -102.14 154.58 18.88 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.805 0.336 . . . . 73.549999999999997 110.927 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . 0.415 ' O ' HD23 ' A' ' 9' ' ' LEU . 6.9 p80 -132.99 141.93 48.57 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.218 -0.446 . . . . 71.329999999999998 110.886 179.915 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -84.95 107.77 17.25 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.205 -0.452 . . . . 65.099999999999994 110.946 -179.862 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.827 HG21 HD12 ' A' ' 10' ' ' ILE . 0.0 OUTLIER -103.32 161.57 22.66 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.569 0.699 . . . . 73.120000000000005 111.108 -179.933 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.421 ' HD2' ' HB ' ' A' ' 5' ' ' THR . 53.7 Cg_endo -69.77 -19.87 35.51 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.656 2.238 . . . . 74.140000000000001 112.376 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 10.1 m-85 -97.06 -31.66 12.38 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.172 -0.467 . . . . 63.299999999999997 110.883 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 161.62 138.63 2.46 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.761 -0.733 . . . . 73.439999999999998 112.492 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.415 HD23 ' O ' ' A' ' 3' ' ' HIS . 0.6 OUTLIER -53.92 134.63 43.0 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.832 0.348 . . . . 73.329999999999998 110.931 -179.907 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.827 HD12 HG21 ' A' ' 5' ' ' THR . 8.2 mt -131.38 143.55 40.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.187 -0.461 . . . . 72.329999999999998 111.143 179.863 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -127.65 144.74 51.05 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.157 -0.474 . . . . 74.120000000000005 110.848 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 6.0 m-85 . . . . . 0 C--N 1.329 -0.315 0 CA-C-N 116.142 -0.481 . . . . 64.450000000000003 110.932 -179.992 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.369 0 N-CA-C 112.47 -0.252 . . . . 74.219999999999999 112.47 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 9.7 m -95.45 154.47 17.19 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.876 0.37 . . . . 63.219999999999999 110.864 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . 0.415 ' O ' HD23 ' A' ' 9' ' ' LEU . 6.9 p80 -132.76 141.82 48.71 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.191 -0.459 . . . . 63.200000000000003 110.887 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -84.94 107.4 17.06 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.194 -0.457 . . . . 73.420000000000002 110.889 -179.801 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.844 HG21 HD12 ' A' ' 10' ' ' ILE . 0.1 OUTLIER -102.95 161.52 22.88 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.535 0.683 . . . . 74.030000000000001 111.165 -179.995 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.425 ' HD2' ' HB ' ' A' ' 5' ' ' THR . 53.3 Cg_endo -69.83 -19.67 35.48 Favored 'Trans proline' 0 N--CA 1.465 -0.161 0 C-N-CA 122.694 2.263 . . . . 74.439999999999998 112.338 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 10.4 m-85 -97.13 -31.65 12.36 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.186 -0.461 . . . . 73.120000000000005 110.899 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 161.5 138.48 2.43 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.788 -0.72 . . . . 61.049999999999997 112.54 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.415 HD23 ' O ' ' A' ' 3' ' ' HIS . 0.7 OUTLIER -53.79 134.5 42.3 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.794 0.331 . . . . 51.229999999999997 110.93 -179.905 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.844 HD12 HG21 ' A' ' 5' ' ' THR . 7.8 mt -131.35 143.63 40.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.187 -0.461 . . . . 63.229999999999997 111.085 179.887 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -127.7 145.49 50.88 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.159 -0.473 . . . . 73.329999999999998 110.877 179.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 7.2 m-85 . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.2 -0.454 . . . . 71.209999999999994 110.865 -179.947 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.342 0 N-CA-C 112.51 -0.236 . . . . 63.030000000000001 112.51 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 9.8 m -104.46 154.37 19.96 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.877 0.37 . . . . 62.350000000000001 110.901 -179.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 6.9 p80 -133.03 142.6 48.89 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.178 -0.465 . . . . 75.219999999999999 110.839 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -85.66 107.57 17.61 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.255 -0.429 . . . . 75.519999999999996 110.922 -179.855 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.837 HG21 HD12 ' A' ' 10' ' ' ILE . 0.1 OUTLIER -103.14 161.57 22.69 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.616 0.722 . . . . 74.120000000000005 111.102 -179.943 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.423 ' HD2' ' HB ' ' A' ' 5' ' ' THR . 53.8 Cg_endo -69.8 -19.62 35.68 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.683 2.256 . . . . 64.140000000000001 112.319 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 10.3 m-85 -97.17 -31.67 12.34 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.226 -0.443 . . . . 65.439999999999998 110.87 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 161.5 138.6 2.46 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.796 -0.716 . . . . 60.25 112.507 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -53.84 134.52 42.56 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.796 0.331 . . . . 71.409999999999997 110.924 -179.943 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.837 HD12 HG21 ' A' ' 5' ' ' THR . 7.9 mt -131.32 143.63 40.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.177 -0.465 . . . . 75.019999999999996 111.14 179.833 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -127.85 145.33 50.97 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.137 -0.483 . . . . 64.239999999999995 110.884 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 7.6 m-85 . . . . . 0 C--N 1.328 -0.348 0 CA-C-N 116.156 -0.475 . . . . 74.129999999999995 110.896 -179.98 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.33 0 N-CA-C 112.503 -0.239 . . . . 33.32 112.503 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 9.5 m -103.59 154.43 19.5 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.887 0.375 . . . . 71.409999999999997 110.867 -179.892 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . 0.419 ' O ' HD23 ' A' ' 9' ' ' LEU . 6.9 p80 -132.59 141.71 48.81 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.13 -0.486 . . . . 52.32 110.834 179.913 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -84.72 107.62 17.01 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.178 -0.465 . . . . 64.099999999999994 110.915 -179.833 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.832 HG21 HD12 ' A' ' 10' ' ' ILE . 0.1 OUTLIER -103.23 161.58 22.65 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.629 0.728 . . . . 41.409999999999997 111.13 -179.987 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.422 ' HD2' ' HB ' ' A' ' 5' ' ' THR . 53.3 Cg_endo -69.74 -19.88 35.65 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.731 2.288 . . . . 61.100000000000001 112.322 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 10.1 m-85 -97.0 -31.84 12.31 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.231 -0.44 . . . . 72.019999999999996 110.89 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 161.66 138.57 2.45 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.732 -0.747 . . . . 13.52 112.48 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.419 HD23 ' O ' ' A' ' 3' ' ' HIS . 0.7 OUTLIER -53.79 134.55 42.31 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.815 0.341 . . . . 74.239999999999995 110.892 -179.927 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.832 HD12 HG21 ' A' ' 5' ' ' THR . 8.0 mt -131.32 143.57 40.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.218 -0.446 . . . . 61.340000000000003 111.109 179.81 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -127.5 144.56 51.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.147 -0.479 . . . . 64.219999999999999 110.872 179.885 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 116.18 -0.464 . . . . 64.439999999999998 110.84 -179.956 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.357 0 N-CA-C 112.478 -0.249 . . . . 73.019999999999996 112.478 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 9.5 m -91.76 154.36 18.99 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.896 0.379 . . . . 74.099999999999994 110.903 -179.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 6.9 p80 -132.97 142.47 48.88 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.19 -0.459 . . . . 60.130000000000003 110.856 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -85.53 107.47 17.48 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.224 -0.443 . . . . 65.010000000000005 110.906 -179.846 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.845 HG21 HD12 ' A' ' 10' ' ' ILE . 0.1 OUTLIER -103.02 161.59 22.65 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-O 121.604 0.716 . . . . 75.420000000000002 111.122 -179.967 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.426 ' HD2' ' HB ' ' A' ' 5' ' ' THR . 53.3 Cg_endo -69.79 -19.77 35.54 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.731 2.287 . . . . 73.010000000000005 112.313 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 10.3 m-85 -97.06 -31.63 12.39 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.19 -0.459 . . . . 73.450000000000003 110.876 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 161.44 138.6 2.46 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.736 -0.745 . . . . 54.439999999999998 112.469 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -53.78 134.55 42.23 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.826 0.346 . . . . 75.430000000000007 110.919 -179.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.845 HD12 HG21 ' A' ' 5' ' ' THR . 7.9 mt -131.36 143.56 40.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.137 -0.483 . . . . 72.540000000000006 111.116 179.843 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -127.85 144.4 51.09 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.2 -0.454 . . . . 72.209999999999994 110.859 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 7.2 m-85 . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 116.167 -0.469 . . . . 70.5 110.878 -179.947 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.335 0 N-CA-C 112.44 -0.264 . . . . 70.420000000000002 112.44 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 9.6 m -100.2 154.71 18.23 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.91 0.386 . . . . 73.129999999999995 110.889 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 6.9 p80 -133.1 141.52 48.23 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.163 -0.471 . . . . 72.319999999999993 110.829 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -84.66 107.48 16.89 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.208 -0.451 . . . . 72.049999999999997 110.888 -179.844 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.833 HG21 HD12 ' A' ' 10' ' ' ILE . 0.1 OUTLIER -103.05 161.56 22.73 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.6 0.714 . . . . 71.420000000000002 111.135 179.989 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.423 ' HD2' ' HB ' ' A' ' 5' ' ' THR . 53.9 Cg_endo -69.82 -19.74 35.44 Favored 'Trans proline' 0 C--O 1.231 0.17 0 C-N-CA 122.704 2.27 . . . . 74.5 112.324 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 10.3 m-85 -97.1 -31.63 12.38 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.229 -0.441 . . . . 64.530000000000001 110.862 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 161.56 138.57 2.45 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.77 -0.729 . . . . 75.150000000000006 112.529 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -53.87 134.59 42.75 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.826 0.345 . . . . 74.319999999999993 110.893 -179.918 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.833 HD12 HG21 ' A' ' 5' ' ' THR . 8.0 mt -131.37 143.4 40.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.156 -0.474 . . . . 73.409999999999997 111.141 179.861 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -127.76 144.03 51.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.178 -0.464 . . . . 70.409999999999997 110.872 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 6.9 m-85 . . . . . 0 C--N 1.328 -0.33 0 CA-C-N 116.196 -0.456 . . . . 62.210000000000001 110.877 -179.968 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.302 0 N-CA-C 112.495 -0.242 . . . . 54.329999999999998 112.495 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 9.7 m -102.57 154.71 18.86 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.852 0.358 . . . . 63.420000000000002 110.901 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 6.9 p80 -133.04 141.85 48.46 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.212 -0.449 . . . . 61.439999999999998 110.887 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -84.98 107.53 17.15 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.195 -0.457 . . . . 75.140000000000001 110.927 -179.85 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.834 HG21 HD12 ' A' ' 10' ' ' ILE . 0.1 OUTLIER -103.12 161.56 22.74 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.55 0.69 . . . . 63.030000000000001 111.13 -179.97 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.424 ' HD2' ' HB ' ' A' ' 5' ' ' THR . 53.7 Cg_endo -69.75 -19.64 35.92 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.633 2.222 . . . . 72.040000000000006 112.336 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 10.4 m-85 -97.16 -31.76 12.3 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.221 -0.445 . . . . 75.010000000000005 110.894 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 161.64 138.67 2.47 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.737 -0.744 . . . . 60.130000000000003 112.483 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -53.88 134.54 42.81 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.764 0.316 . . . . 74.120000000000005 110.879 -179.91 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.834 HD12 HG21 ' A' ' 5' ' ' THR . 8.0 mt -131.42 143.67 39.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.187 -0.461 . . . . 74.409999999999997 111.16 179.815 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -127.67 139.1 52.92 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.186 -0.461 . . . . 73.019999999999996 110.86 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 6.2 m-85 . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.14 -0.482 . . . . 71.409999999999997 110.877 179.999 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.325 0 N-CA-C 112.469 -0.252 . . . . 72.439999999999998 112.469 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 9.5 m -96.04 154.42 17.25 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.87 0.367 . . . . 74.409999999999997 110.885 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 6.9 p80 -133.01 142.82 49.03 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.204 -0.453 . . . . 75.439999999999998 110.909 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -85.79 107.79 17.8 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.215 -0.448 . . . . 64.129999999999995 110.907 -179.822 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.819 HG21 HD12 ' A' ' 10' ' ' ILE . 0.0 OUTLIER -103.29 161.62 22.53 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.588 0.709 . . . . 74.340000000000003 111.14 -179.997 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.419 ' HD2' ' HB ' ' A' ' 5' ' ' THR . 53.2 Cg_endo -69.84 -19.55 35.58 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.665 2.243 . . . . 72.420000000000002 112.316 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 10.3 m-85 -97.33 -31.8 12.21 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.24 -0.436 . . . . 74.140000000000001 110.846 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 161.68 138.75 2.49 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.768 -0.73 . . . . 54.530000000000001 112.491 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -53.84 134.64 42.56 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.77 0.319 . . . . 73.439999999999998 110.933 -179.912 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.819 HD12 HG21 ' A' ' 5' ' ' THR . 8.8 mt -131.31 143.44 40.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.193 -0.458 . . . . 62.409999999999997 111.112 179.841 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -127.89 145.1 51.06 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.207 -0.451 . . . . 61.049999999999997 110.874 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 . . . . . 0 C--N 1.33 -0.263 0 CA-C-N 116.168 -0.469 . . . . 62.100000000000001 110.882 -179.965 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.301 0 N-CA-C 112.533 -0.227 . . . . 62.329999999999998 112.533 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 9.8 m -99.87 154.7 18.14 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.829 0.347 . . . . 64.299999999999997 110.888 -179.898 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 6.9 p80 -133.03 142.36 48.76 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.188 -0.46 . . . . 74.140000000000001 110.863 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -85.38 107.75 17.51 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.25 -0.432 . . . . 63.539999999999999 110.973 -179.89 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.826 HG21 HD12 ' A' ' 10' ' ' ILE . 0.1 OUTLIER -103.32 161.55 22.72 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.619 0.723 . . . . 61.420000000000002 111.12 -179.942 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.422 ' HD2' ' HB ' ' A' ' 5' ' ' THR . 53.8 Cg_endo -69.72 -19.49 36.26 Favored 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.687 2.258 . . . . 64.030000000000001 112.342 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 10.4 m-85 -97.43 -31.84 12.16 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.218 -0.446 . . . . 72.329999999999998 110.855 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 161.72 138.64 2.47 Favored Glycine 0 N--CA 1.451 -0.367 0 C-N-CA 120.757 -0.735 . . . . 52.219999999999999 112.479 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -53.82 134.53 42.47 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.808 0.337 . . . . 70.209999999999994 110.934 -179.946 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.826 HD12 HG21 ' A' ' 5' ' ' THR . 8.3 mt -131.35 143.64 40.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.182 -0.463 . . . . 72.530000000000001 111.121 179.825 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -127.47 138.58 52.99 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.143 -0.48 . . . . 62.509999999999998 110.887 179.921 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 6.4 m-85 . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 116.142 -0.481 . . . . 71.400000000000006 110.862 -179.968 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.312 0 N-CA-C 112.515 -0.234 . . . . 52.100000000000001 112.515 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 9.2 m -100.34 154.6 18.36 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.828 0.346 . . . . 73.120000000000005 110.907 -179.916 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 6.9 p80 -133.03 143.32 49.31 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.193 -0.458 . . . . 72.129999999999995 110.86 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -86.01 107.87 17.98 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.211 -0.45 . . . . 72.450000000000003 110.958 -179.869 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.824 HG21 HD12 ' A' ' 10' ' ' ILE . 0.0 OUTLIER -103.47 161.65 22.4 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-O 121.598 0.713 . . . . 53.420000000000002 111.129 -179.962 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.422 ' HD2' ' HB ' ' A' ' 5' ' ' THR . 54.2 Cg_endo -69.74 -20.25 35.17 Favored 'Trans proline' 0 C--N 1.341 0.148 0 C-N-CA 122.71 2.273 . . . . 71.120000000000005 112.365 179.883 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 10.0 m-85 -96.68 -31.75 12.54 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.216 -0.447 . . . . 62.049999999999997 110.843 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 161.49 138.88 2.52 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.783 -0.722 . . . . 62.009999999999998 112.489 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -53.83 134.76 42.49 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.815 0.34 . . . . 71.230000000000004 110.914 -179.929 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.824 HD12 HG21 ' A' ' 5' ' ' THR . 8.8 mt -131.37 143.51 40.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.222 -0.444 . . . . 72.409999999999997 111.125 179.827 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -127.88 141.81 51.45 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.167 -0.469 . . . . 74.140000000000001 110.884 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 5.8 m-85 . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 116.196 -0.456 . . . . 53.229999999999997 110.88 -179.959 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.28 0 N-CA-C 112.526 -0.23 . . . . 64.409999999999997 112.526 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 8.9 m -91.01 153.53 20.08 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.892 0.377 . . . . 65.349999999999994 110.875 -179.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 6.8 p80 -133.18 141.99 48.39 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.154 -0.476 . . . . 70.420000000000002 110.884 179.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -84.93 107.4 17.05 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.203 -0.453 . . . . 74.099999999999994 110.913 -179.871 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.828 HG21 HD12 ' A' ' 10' ' ' ILE . 0.1 OUTLIER -102.96 161.6 22.63 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.584 0.707 . . . . 72.140000000000001 111.122 -179.981 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.424 ' HD2' ' HB ' ' A' ' 5' ' ' THR . 53.2 Cg_endo -69.76 -19.93 35.5 Favored 'Trans proline' 0 C--O 1.232 0.181 0 C-N-CA 122.685 2.256 . . . . 72.439999999999998 112.339 179.946 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 10.2 m-85 -96.96 -31.5 12.51 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.198 -0.455 . . . . 73.530000000000001 110.863 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 161.52 138.63 2.46 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.696 -0.764 . . . . 32.119999999999997 112.487 -179.899 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -53.85 134.66 42.61 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.788 0.328 . . . . 72.219999999999999 110.941 -179.949 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.828 HD12 HG21 ' A' ' 5' ' ' THR . 8.8 mt -131.46 143.65 39.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.205 -0.452 . . . . 71.439999999999998 111.116 179.877 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -127.25 132.83 50.29 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.203 -0.453 . . . . 72.519999999999996 110.891 179.935 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 7.4 m-85 . . . . . 0 C--N 1.329 -0.326 0 CA-C-N 116.186 -0.461 . . . . 53.43 110.859 -179.935 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.309 0 N-CA-C 112.491 -0.244 . . . . 65.540000000000006 112.491 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 11.3 m -109.34 156.61 19.78 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.849 0.357 . . . . 54.119999999999997 110.854 -179.888 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 7.7 p80 -130.66 140.5 50.39 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.16 -0.473 . . . . 71.319999999999993 110.844 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -82.73 110.62 17.93 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.212 -0.449 . . . . 74.120000000000005 110.928 -179.867 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.841 HG21 HD12 ' A' ' 10' ' ' ILE . 0.0 OUTLIER -106.77 161.64 22.24 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.583 0.706 . . . . 71.219999999999999 111.136 -179.96 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.422 ' HD2' ' HB ' ' A' ' 5' ' ' THR . 53.6 Cg_endo -69.77 -19.45 36.05 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.691 2.261 . . . . 73.049999999999997 112.314 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 10.1 m-85 -97.75 -31.78 12.07 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.202 -0.454 . . . . 54.399999999999999 110.887 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 161.37 138.71 2.48 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.722 -0.751 . . . . 72.019999999999996 112.488 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -53.75 133.82 42.15 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.79 0.329 . . . . 65.010000000000005 110.941 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.841 HD12 HG21 ' A' ' 5' ' ' THR . 7.5 mt -131.39 143.95 39.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.198 -0.456 . . . . 71.329999999999998 111.173 179.825 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -123.03 152.93 40.49 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.16 -0.473 . . . . 45.039999999999999 110.889 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 4.7 p90 . . . . . 0 C--N 1.329 -0.323 0 CA-C-N 116.196 -0.456 . . . . 65.230000000000004 110.905 -179.979 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.358 0 N-CA-C 112.538 -0.225 . . . . 62.329999999999998 112.538 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 11.4 m -107.7 156.43 19.1 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.885 0.374 . . . . 74.510000000000005 110.863 -179.918 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 7.7 p80 -130.42 140.57 50.57 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.147 -0.479 . . . . 73.340000000000003 110.898 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -82.8 110.71 18.06 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.227 -0.442 . . . . 65.150000000000006 110.9 -179.846 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.844 HG21 HD12 ' A' ' 10' ' ' ILE . 0.0 OUTLIER -106.91 161.67 22.16 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-O 121.558 0.695 . . . . 64.219999999999999 111.14 -179.981 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.423 ' HD2' ' HB ' ' A' ' 5' ' ' THR . 53.1 Cg_endo -69.81 -19.41 35.94 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.682 2.254 . . . . 61.5 112.309 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 10.0 m-85 -97.7 -31.89 12.03 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.224 -0.444 . . . . 64.400000000000006 110.892 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 161.42 138.72 2.49 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.731 -0.747 . . . . 70.109999999999999 112.51 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -53.81 133.99 42.45 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.842 0.353 . . . . 53.009999999999998 110.865 -179.88 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.844 HD12 HG21 ' A' ' 5' ' ' THR . 7.5 mt -131.44 143.92 39.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.175 -0.466 . . . . 72.219999999999999 111.105 179.866 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -123.11 152.79 40.75 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.184 -0.462 . . . . 71.329999999999998 110.915 179.885 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 4.8 p90 . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.151 -0.477 . . . . 71.519999999999996 110.84 -179.941 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.319 0 N-CA-C 112.504 -0.238 . . . . 65.030000000000001 112.504 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 9.9 m -100.81 154.7 18.42 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.854 0.359 . . . . 72.340000000000003 110.887 -179.896 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 7.3 p80 -132.9 141.25 48.28 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.184 -0.462 . . . . 65.319999999999993 110.874 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -84.97 106.45 16.48 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.185 -0.462 . . . . 72.329999999999998 110.871 -179.82 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.687 HG21 HD12 ' A' ' 10' ' ' ILE . 0.1 OUTLIER -102.84 161.24 23.77 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.594 0.711 . . . . 73.340000000000003 111.15 179.982 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.447 ' HD2' ' HB ' ' A' ' 5' ' ' THR . 53.7 Cg_endo -69.81 -18.2 36.91 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.707 2.271 . . . . 71.120000000000005 112.316 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 13.8 m-85 -97.64 -31.34 12.34 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.201 -0.454 . . . . 73.200000000000003 110.856 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 160.2 138.04 2.35 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.755 -0.736 . . . . 51.420000000000002 112.47 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -53.86 133.48 42.72 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.812 0.339 . . . . 74.430000000000007 110.863 -179.88 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.687 HD12 HG21 ' A' ' 5' ' ' THR . 8.3 mt -131.4 143.51 40.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.165 -0.47 . . . . 70.450000000000003 111.116 179.85 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -126.62 142.51 51.51 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.193 -0.458 . . . . 74.019999999999996 110.884 179.904 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 . . . . . 0 C--N 1.329 -0.323 0 CA-C-N 116.18 -0.464 . . . . 72.140000000000001 110.868 -179.923 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.318 0 N-CA-C 112.477 -0.249 . . . . 54.32 112.477 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 9.3 m -95.08 153.63 17.55 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.857 0.361 . . . . 53.310000000000002 110.874 -179.89 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . 0.541 ' O ' HD23 ' A' ' 9' ' ' LEU . 7.8 p80 -132.99 144.79 50.33 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.186 -0.461 . . . . 54.43 110.874 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -87.55 111.14 20.91 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.272 -0.422 . . . . 70.510000000000005 110.895 -179.827 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.55 HG21 HD12 ' A' ' 10' ' ' ILE . 0.1 OUTLIER -107.92 161.45 23.25 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-O 121.593 0.711 . . . . 73.239999999999995 111.14 -179.971 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.43 ' HD2' ' HB ' ' A' ' 5' ' ' THR . 53.5 Cg_endo -69.8 -18.71 36.66 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.646 2.23 . . . . 64.510000000000005 112.301 -180.0 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 11.9 m-85 -97.61 -31.32 12.36 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.238 -0.437 . . . . 74.530000000000001 110.837 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 159.99 138.02 2.35 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.748 -0.739 . . . . 61.350000000000001 112.48 -179.933 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.541 HD23 ' O ' ' A' ' 3' ' ' HIS . 0.7 OUTLIER -53.96 134.45 43.26 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.749 0.309 . . . . 75.540000000000006 110.874 -179.913 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.55 HD12 HG21 ' A' ' 5' ' ' THR . 14.5 mt -131.34 142.73 42.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.176 -0.466 . . . . 64.140000000000001 111.142 179.799 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -126.64 144.19 50.98 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.14 -0.482 . . . . 72.150000000000006 110.857 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 6.7 m-85 . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 116.167 -0.469 . . . . 71.219999999999999 110.911 179.996 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.279 0 N-CA-C 112.477 -0.249 . . . . 40.119999999999997 112.477 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 11.4 m -104.33 156.56 17.81 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.832 0.349 . . . . 75.519999999999996 110.935 -179.947 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 7.6 p80 -130.28 139.77 50.72 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.214 -0.448 . . . . 74.25 110.828 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -82.15 110.0 16.96 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.222 -0.444 . . . . 71.200000000000003 110.905 -179.824 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.84 HG21 HD12 ' A' ' 10' ' ' ILE . 0.0 OUTLIER -106.17 161.67 22.13 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 121.549 0.69 . . . . 73.329999999999998 111.16 -179.973 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.424 ' HD2' ' HB ' ' A' ' 5' ' ' THR . 53.7 Cg_endo -69.79 -19.53 35.87 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.665 2.243 . . . . 60.43 112.337 179.957 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 10.1 m-85 -97.53 -31.86 12.11 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.246 -0.434 . . . . 72.510000000000005 110.859 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 161.46 138.71 2.48 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.789 -0.719 . . . . 45.140000000000001 112.479 -179.93 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -53.73 133.72 42.03 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.769 0.319 . . . . 52.420000000000002 110.92 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.84 HD12 HG21 ' A' ' 5' ' ' THR . 7.4 mt -131.4 144.03 38.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.154 -0.475 . . . . 62.539999999999999 111.151 179.836 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -122.92 153.82 39.18 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.202 -0.454 . . . . 42.539999999999999 110.876 179.924 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 4.8 p90 . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 116.147 -0.479 . . . . 62.219999999999999 110.945 179.979 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.302 0 N-CA-C 112.442 -0.263 . . . . 72.219999999999999 112.442 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 11.9 m -96.3 156.85 16.17 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.866 0.365 . . . . 71.230000000000004 110.875 -179.885 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 7.7 p80 -130.36 138.6 50.48 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.167 -0.47 . . . . 74.209999999999994 110.836 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -81.22 110.23 16.5 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.216 -0.447 . . . . 73.420000000000002 110.923 -179.84 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.842 HG21 HD12 ' A' ' 10' ' ' ILE . 0.0 OUTLIER -106.54 161.65 22.19 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-O 121.582 0.705 . . . . 52.200000000000003 111.13 -179.962 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.427 ' HD2' ' HB ' ' A' ' 5' ' ' THR . 54.0 Cg_endo -69.74 -19.54 36.1 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.699 2.266 . . . . 62.409999999999997 112.349 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 10.3 m-85 -97.56 -31.63 12.22 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.204 -0.453 . . . . 72.5 110.847 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 161.16 138.74 2.49 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.774 -0.726 . . . . 65.120000000000005 112.506 -179.951 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -53.73 133.83 42.04 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.777 0.322 . . . . 70.450000000000003 110.92 -179.94 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.842 HD12 HG21 ' A' ' 5' ' ' THR . 7.4 mt -131.49 144.0 38.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.202 -0.453 . . . . 44.409999999999997 111.147 179.852 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -123.02 153.55 39.66 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.212 -0.449 . . . . 74.409999999999997 110.915 179.915 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 4.8 p90 . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.169 -0.469 . . . . 61.439999999999998 110.903 -179.978 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.303 0 N-CA-C 112.487 -0.245 . . . . 71.049999999999997 112.487 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 11.1 m -96.83 157.08 16.07 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.887 0.375 . . . . 74.200000000000003 110.878 -179.885 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 7.5 p80 -130.58 138.42 50.14 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.207 -0.452 . . . . 72.120000000000005 110.83 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -81.14 109.48 15.73 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.177 -0.465 . . . . 70.040000000000006 110.915 -179.856 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.839 HG21 HD12 ' A' ' 10' ' ' ILE . 0.0 OUTLIER -105.57 161.6 22.31 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.588 0.709 . . . . 71.340000000000003 111.137 -179.964 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.431 ' HD2' ' HB ' ' A' ' 5' ' ' THR . 53.8 Cg_endo -69.78 -19.49 35.96 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.698 2.265 . . . . 71.450000000000003 112.323 179.962 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 10.2 m-85 -97.52 -31.81 12.14 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.238 -0.437 . . . . 64.540000000000006 110.844 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 161.45 138.69 2.48 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.756 -0.735 . . . . 70.409999999999997 112.481 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -53.73 133.63 42.06 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.808 0.337 . . . . 72.209999999999994 110.881 -179.902 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.839 HD12 HG21 ' A' ' 5' ' ' THR . 7.4 mt -131.4 144.11 38.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.174 -0.466 . . . . 51.109999999999999 111.166 179.818 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -123.08 153.56 39.74 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.219 -0.446 . . . . 45.229999999999997 110.9 179.937 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 4.9 p90 . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 116.212 -0.449 . . . . 74.150000000000006 110.942 179.986 . . . . . . . . 0 0 . 1 stop_ save_